Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Japanese Journal of Pharmacology|September 1, 1986
Inhibition of angiotensin converting enzyme by CV-3317, a non-sulfhydryl compoundY Inada, Z Terashita, Y Imura, et al.Chemical & Pharmaceutical Bulletin|March 20, 2001
Novel non-peptide GPIIb/IIIa antagonists: synthesis and biological activities of 2-[4-[2-(4-amidinobenzoylamino)-2-(substituted)acetyl]-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyl] acetic acidsS Kitamura, H Fukushi, T Miyawaki, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993
TCV-116, a novel angiotensin II receptor antagonist, prevents intimal thickening and impairment of vascular function after carotid injury in ratsM Kawamura, Z Terashita, H Okuda, et al.Journal of Medicinal Chemistry|July 13, 2001
Potent dibasic GPIIb/IIIa antagonists with reduced prolongation of bleeding time: synthesis and pharmacological evaluation of 2-oxopiperazine derivativesS Kitamura, H Fukushi, T Miyawaki, et al.Life Sciences|January 1, 1990
Pathophysiological role of endothelin in acute renal failureY Shibouta, N Suzuki, A Shino, et al.Clinical and Experimental Hypertension|January 1, 1980
Acceleration of hypotension and development of stroke in the spontaneously hypertensive rat by unilateral ureteral obstructionY Inada, Z Terashita, Y Shibouta, et al.Journal of Medicinal Chemistry|January 1, 1989
Platelet activating factor antagonists: synthesis and structure-activity studies of novel PAF analogues modified in the phosphorylcholine moietyM Takatani, Y Yoshioka, A Tasaka, et al.Thrombosis Research|January 15, 1986
CV-4151--a potent, selective thromboxane A2 synthetase inhibitorZ Terashita, Y Imura, M Tanabe, et al.Journal of Medicinal Chemistry|March 4, 1998
Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptideH Sugihara, H Fukushi, T Miyawaki, et al.Journal of Cardiovascular Pharmacology|December 1, 1994
Antihypertensive and cardiovascular effects of a new potassium channel opener, TCV-295, in rats and dogsK Kusumoto, Y Awane, T Kitayoshi, et al.Pageof 6